STAGE III PROSTATE CANCER AJCC V8
Clinical trials for STAGE III PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene test guides prostate cancer treatment: less or more hormone therapy?
Disease control OngoingThis study tests whether personalizing hormone therapy based on a patient's genetic risk score can improve prostate cancer treatment. For patients with a low genetic risk, a shorter course of hormone therapy (12 months instead of 24) with radiation is tested to see if it works ju…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 22, 2026 12:05 UTC
-
Immunotherapy-Chemo combo targets tough neuroendocrine cancers
Disease control OngoingThis early-phase trial tests whether adding the immunotherapy drug pembrolizumab to standard platinum-based chemotherapy can help people with rare, aggressive small cell or neuroendocrine cancers of the bladder or prostate. The study includes 15 participants whose cancer has spre…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 11:58 UTC
-
Promising prostate cancer trial pulled before it even started
Disease control TerminatedThis study was designed to see if adding the immunotherapy drug pembrolizumab to standard hormone therapy and radiation could improve outcomes for men with high-risk prostate cancer that hasn't spread. The trial was withdrawn before enrolling any participants, so no results are a…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 17, 2026 12:07 UTC
-
New bladder tuck may help men stay dry after prostate cancer surgery
Symptom relief TerminatedThis study looks at whether adding a simple bladder support step (vesicopexy) to standard robotic prostate cancer surgery helps men regain bladder control faster and improves their quality of life. About 196 men with early-stage prostate cancer will take part. The main goal is to…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 22, 2026 12:04 UTC
-
Prostate cancer treatment may harm your heart – new study investigates
Knowledge-focused OngoingThis study looks at how certain hormone therapies for prostate cancer affect the heart. It compares two drugs, leuprolide and relugolix, given alongside radiation. The goal is to understand why some men develop heart problems and find ways to predict and reduce that risk. About 9…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC